Does the cost of inhaler devices affect therapy adherence and disease outcomes?

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/17441
• EU PAS number:
  EUPAS13586
• Study ID:
  17441
• Official title and acronym:
  Does the cost of inhaler devices affect therapy adherence and disease outcomes?
• DARWIN EU® study:
  No
• Study countries:
  United Kingdom
• Study description:
  The aim of the study is to investigate whether a raise in prescription costs affects maintenance therapy and disease outcomes in patients with asthma or COPD. The objectives are to characterise patients who pay prescription charges and those who do not (i.e. HSE medical card holders) in an Irish primary care population diagnosed with asthma or COPD and for both groups to assess whether maintenance therapy adherence and disease control is better in patients who do not pay prescription charges compared to those who do pay.
• Study status:
  Finalised

Research institutions and networks

Institutions

Observational & Pragmatic Research Institute Pte (OPRI)

United Kingdom

Study timelines

Date when funding contract was signed

Planned: 09/06/2016

Actual: 09/06/2016

Study start date

Planned: 17/06/2016

Actual: 04/11/2016

Data analysis start date

Planned: 29/07/2016

Actual: 04/11/2016

Date of interim report, if expected

Planned: 15/08/2016

Actual: 11/11/2006

Date of final study report

Planned: 01/11/2016

Actual: 23/11/2016

Sources of funding

Other

More details on funding

RIRL, DASG

Study protocol

Initial protocol

20160526_R00315 Cost of inhaler devices Protocol_swym

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable